Towards early detection and disease interception of COPD across the lifespan
Understanding the Heterogeneity and Burden of COPD
COPD is “a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnoea, cough, sputum production and/or exacerbations) due to abnormalities of the airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction”.
COPD is a major public health problem worldwide. It is the third cause of death globally, affects about 10% of the adult population, is associated with significant morbidity and mortality, and has a huge impact on patients, their families and society.
Shifting Paradigms in COPD Pathogenesis
Our understanding of the pathogenesis of COPD has changed significantly over the past few years.
We review how this new knowledge can inform future clinical strategies directed towards earlier detection and disease interception of COPD across the lifespan, thus reducing its disease burden and improving the well-being and prognosis of COPD patients.
Future Directions and Research Opportunities
This review highlights that our understanding of, and ability to prevent and treat, chronic airway diseases, particularly COPD, is entering a new era.
There are still many questions to be answered, but there are great opportunities for research and, more importantly, to improve the well-being and prognosis of these patients.
Authors
Rosa Faner, Michael H. Cho, Gerard H. Koppelman, Erik Melén, Stijn E. Verleden, Shyamali C. Dharmage, Silke Meiners, Alvar Agusti
Read more details at
Fecha de publicación
9 July 2025
Categorías asociadas al artículo
Noticias relacionadas
Predictores de progresión en la pre-EPOC: estudio 3P, justificación y diseño
Conoce el estudio 3P que analiza los factores que predicen la progresión de la pre-EPOC a EPOC en fumadores con espirometría normal.
GOLD Science Committee recommendations for the use of pre- and post-bronchodilator spirometry to diagnose of COPD
Siprometry to diagnose COPD: GOLD 2025 recommends using pre-BD spirometry to rule out COPD and post-BD to confirm, ensuring volume responders are not overlooked.
Joint statement from GOLD/GLI regarding the use of spirometry to define airflow obstruction and diagnose COPD
GOLD and GLI provide a joint position on spirometry for diagnosing COPD, supporting the fixed FEV1/FVC ratio in the appropriate clinical context.
A Brief History of COPD: As Told by Some of Its Senior Scientists and Clinicians
Explore the history of COPD and the evolution of disease concepts, treatment strategies, patient outcomes, pulmonary rehabilitation and clinical management.
High prevalence of obstructive sleep apnea in patients with Long-COVID
Sleep apnea is highly prevalent in Long-COVID patients. Sleep studies may help identify treatable causes of persistent symptoms and insomnia.
Indoor radon exposure and COPD in never smokers: a case–control study in a radon-prone area in Spain
Study on indoor radon exposure and its association with COPD risk and severity in never smokers in a radon-prone region.
Imagen desarrollada por IA